Recruited bone marrow cells expressing the EP3 prostaglandin E receptor subtype enhance angiogenesis during chronic inflammation

Biomedicine and Pharmacotherapy

Volumn 64, Issue 2, 2010, Pages 93-100

  Ueno, T ^a   Suzuki, T ^a   Oikawa, A ^a   Hosono, K ^a   Kosaka, Y ^a   Amano, H ^a   Kitasato, H ^b   Toda, M ^a   Hayashi, I ^c   Kato, T ^a   Ito, Y ^a   Sugimoto, Y ^d   Narumiya, S ^e   Okamoto, H ^a   Majima, M ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c NIHON PHARMACEUTICAL UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e KYOTO UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Bone marrow cells; EP3 receptor; Mac 1; Prostaglandins

Indexed keywords

ACETYLSALICYLIC ACID; CD11B ANTIGEN; CD31 ANTIGEN; CELECOXIB; COLLAGENASE; GREEN FLUORESCENT PROTEIN; PROSTAGLANDIN E RECEPTOR; VASCULOTROPIN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL FRACTIONATION; CHRONIC INFLAMMATION; CONTROLLED STUDY; DRUG MEGADOSE; DRUG PROTEIN BINDING; GRANULATION TISSUE; KNOCKOUT MOUSE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DISEASE MODELS, ANIMAL; GRANULATION TISSUE; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; NEUTROPHIL INFILTRATION; PYRAZOLES; RECEPTORS, PROSTAGLANDIN E; SULFONAMIDES;

EID: 77349120257     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2009.04.034     Document Type: Article

References (37)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst 1990, 82:4-6.
2. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971, 285:1182-1186.
3. Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86:353-364.
4. Ferrara N., Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 1999, 5:1359-1364.
5. Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 1995, 333:1757-1763.
6. Lyden D., Hattori K., Dias S., et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001, 7:1194-1201.
7. Wragg A., Mellad J.A., Beltran L.E., Konoplyannikov M., San H., Boozer S., et al. VEGFR1/CXCR4-positive progenitor cells modulate local inflammation and augment tissue perfusion by a SDF-1-dependent mechanism. J Mol Med 2008, 86(11):1221-1232.
8. Popa E.R., Harmsen M.C., Tio R.A., van der Strate B.W., Brouwer L.A., Schipper M., et al. Circulating CD34+ progenitor cells modulate host angiogenesis and inflammation in vivo. J Mol Cell Cardiol 2006, 41(1):86-96.
9. Zijlstra A., Seandel M., Kupriyanova T.A., Partridge J.J., Madsen M.A., Hahn-Dantona E.A., et al. Proangiogenic role of neutrophil-like inflammatory heterophiles during neovascularization induced by growth factors and human tumor cells. Blood 2006, 107(1):317-327.
10. Moldovan L., Moldovan N.I. Role of monocytes and macrophages in angiogenesis. EXS 2005, 94:127-146.
11. Solowiej A., Biswas P., Graesser D., Madri J.A. Lack of platelet endothelial cell adhesion molecule-1 attenuates foreign body inflammation because of decreased angiogenesis. Am J Pathol 2003, 162(3):953-962.
12. Majima M., Amano H., Hayashi I. Prostanoid receptor signaling relevant to tumor growth and angiogenesis. Trends Pharmacol Sci 2003, 24:524-529.
13. Oshima M., Dinchuk J.E., Kargman S.L., Oshima H., Hancock B., Kwong E., et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996, 87(5):803-809.
14. Katori M., Majima M. Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors. Inflamm Res 2000, 49(8):367-392.
15. Bresalier R.S., Sandler R.S., Quan H., Bolognese J.A., Oxenius B., Horgan K., et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005, 352(11):1092-1102.
16. Majima M., Hayashi I., Muramatsu M., Katada J., Yamashina S., Katori M. Cyclo oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br J Pharmacol 2000, 130(3):641-649.
17. Majima M., Isono M., Ikeda Y., Hayashi I., Hatanaka K., Harada Y., et al. Significant roles of inducible cyclooxygenase (COX)-2 in angiogenesis in rat sponge implants. Jpn J Pharmacol 1997, 75(2):105-114.
18. Amano H., Hayashi I., Endo H., et al. Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. J Exp Med 2003, 197:221-232.
19. Kamoshita E., Ikeda Y., Fujita M., et al. Recruitment of a prostaglandin E receptor subtype, EP3-expressing bone marrow cells is crucial in wound-induced angiogenesis. Am J Pathol 2006, 169:1458-1472.
20. Fujita M., Hayashi I., Yamashina S., Fukamizu A., Itoman M., Majima M. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Carcinogenesis 2005, 26:271-279.
21. Yoshida S., Amano H., Hayashi I., et al. COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo. Lab Invest 2003, 83:1385-1394.
22. Ikeda Y., Hayashi I., Kamoshita E., Yamazaki A., Endo H., Ishihara K., et al. Host stromal bradykinin B2 receptor signaling facilitates tumor-associated angiogenesis and tumor growth. Cancer Res 2004, 64(15):5178-5185.
23. Oikawa A., Ito K., Seguchi H., Okabe M., Migishima F., Eshima K., et al. Development of immunocompetent lymphocytes in vivo from murine umbilical cord blood cells. Transplantation 2007, 84(1):23-30.
24. Migishima F., Oikawa A., Kondo S., Ema H., Morita Y., Nakauchi H., et al. Full reconstitution of hematopoietic system by murine umbilical cord blood. Transplantation 2003, 75(11):1820-1826.
25. Toda M., Suzuki T., Hosono K., Hayashi I., Hashiba S., Onuma Y., et al. Neuronal system-dependent facilitation of tumor angiogenesis and tumor growth by calcitonin gene-related peptide. Proc Natl Acad Sci U S A 2008, 105(36):13550-13555.
26. Ohno T., Hattori Y., Komine R., Ae T., Mizuguchi S., Arai K., et al. Roles of calcitonin gene-related peptide in maintenance of gastric mucosal integrity and in enhancement of ulcer healing and angiogenesis. Gastroenterology 2008, 134(1):215-225.
27. Toda M., Suzuki T., Hosono K., Kurihara Y., Kurihara H., Hayashi I., et al. Roles of calcitonin gene-related peptide in facilitation of wound healing and angiogenesis. Biomed Pharmacother 2008, 62(6):352-359.
28. Roccaro A.M., Russo F., Cirulli T., Di Pietro G., Vacca A., Dammacco F. Antiangiogenesis for rheumatoid arthritis. Curr Drug Targets Inflamm Allergy 2005, 4(1):27-30.
29. Amano H., Ando K., Minamida S., Hayashi I., Ogino M., Yamashina S., et al. Adenylate cyclase/protein kinase A signaling pathway enhances angiogenesis through induction of vascular endothelial growth factor in vivo. Jpn J Pharmacol 2001, 87(3):181-188.
30. Narumiya S., Sugimoto Y., Ushikubi F. Prostanoid receptors: structures, properties, and function. Physiol Rev 1999, 79:1193-1226.
31. Wang K., Tarakji K., Zhou Z., Zhang M., Forudi F., Zhou X., et al. Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury model. J Cardiovasc Pharmacol 2005, 45(1):61-67.
32. Scandella E., Men Y., Gillessen S., Förster R., Groettrup M. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 2002, 100(4):1354-1361.
33. Schneider A., Harendza S., Zahner G., Jocks T., Wenzel U., Wolf G., et al. Cyclooxygenase metabolites mediate glomerular monocyte chemoattractant protein-1 formation and monocyte recruitment in experimental glomerulonephritis. Kidney Int 1999, 55(2):430-441.
34. Sun L.K., Reding T., Bain M., Heikenwalder M., Bimmler D., Graf R. Prostaglandin E2 modulates TNF-alpha-induced MCP-1 synthesis in pancreatic acinar cells in a PKA- dependent manner. Am J Physiol Gastrointest Liver Physiol 2007, 293(6). G1196-204.
35. Lorenz M., Slaughter H.S., Wescott D.M., Carter S.I., Schnyder B., Dinchuk J.E., et al. Cyclooxygenase-2 is essential for normal recovery from 5-fluorouracil-induced myelotoxicity in mice. Exp Hematol 1999, 27(10):1494-1502.
36. Tanaka N., Sato T., Fujita H., Morita I. Constitutive expression and involvement of cyclooxygenase-2 in human megakaryocytopoiesis. Arterioscler Thromb Vasc Biol 2004, 24(3):607-612.
37. Lord A.M., North T.E., Zon L.I. Prostaglandin E2: making more of your marrow. Cell Cycle 2007, 6(24):3054-3057.